The full form of ADT in medical term is Androgen deprivation therapy . The mainstay of palliative care for advanced and metastatic prostate cancer for many years has been androgen deprivation therapy (ADT). Additionally, it is being utilized more frequently in patients with limited illnesses.
To spread, prostate cancer requires testosterone. Your body’s production of testosterone can be decreased to stop cancer growth or cause it to shrink temporarily. Androgen deprivation therapy is the medical term for this procedure because testosterone is an androgen, or male sex hormone (ADT). Another name for it is hormone therapy.
After a radical prostatectomy or in conjunction with radiation therapy, ADT may be used to treat locally advanced cancer. Additionally, it might be administered to treat advanced prostate cancer.
The most popular type of ADT includes injecting medication to stop testosterone production. Your doctor or a specialist can administer the shots. To improve the likelihood of successfully eliminating the malignancy, ADT injections could also be administered before, during, and then after radiation therapy. They occasionally go together with chemotherapy.
Anybody else with prostate cancer shouldn’t receive ADT. Following radiation therapy or radical prostatectomy, just having a rising PSA is not a sufficient justification for a doctor to start you on ADT. It’s not a good enough explanation when your doctor wishes to begin you on ADT to “shrink your prostate” before brachytherapy.